← Open Payments lookup

CATHERINE MAJOR: Open Payments

NPI 1467437582 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$979 in 47 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $907 · 2025 $979

Food & beverage: $979
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$219
ABBVIE INC.13$186
Otsuka America Pharmaceutical, Inc.5$113
Neurocrine BioSciences, Inc.6$108
Janssen Pharmaceuticals, Inc4$105
Takeda Pharmaceuticals U.S.A., Inc.4$80
E.R. Squibb & Sons, L.L.C.3$64
Alkermes, Inc.2$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Collegium Pharmaceutical, Inc.1$14

Products named: VRAYLAR, UZEDY, INGREZZA, INVEGA SUSTENNA, TRINTELLIX, COBENFY, REXULTI, ARISTADA.

Industry payments across MA — which companies pay providers there.